Waldencast PLC (NASDAQ:WALD – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $4.9667.
WALD has been the topic of a number of analyst reports. Telsey Advisory Group decreased their price target on Waldencast from $4.00 to $3.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Waldencast in a report on Wednesday, October 8th.
View Our Latest Research Report on Waldencast
Hedge Funds Weigh In On Waldencast
Waldencast Trading Up 1.1%
WALD opened at $1.82 on Friday. Waldencast has a 12 month low of $1.48 and a 12 month high of $4.18. The business’s 50-day moving average price is $1.87 and its 200-day moving average price is $2.16.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Recommended Stories
- Five stocks we like better than Waldencast
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- High Dividend REITs: Are They an Ideal Way to Diversify?
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
